Abstract:Zika virus (ZIKV) infection has potential result in severe birth effects. An improved understanding of global trend and regional differences is needed. Annual ZIKV infection episodes and incidence rates were collected from Global Burden of Disease Study 2019. Episodes changes and estimated annual percentage changes (EAPCs) of age-standardized incidence rate (ASR) were calculated. Top passenger airport-pairs were obtained from the International Air Transport Association to understand places susceptible to imported ZIKV cases. Globally, the ASR increased by an average of 72.85% (95%CI: 16.47% to 156.53%) per year from 2011 to 2015 and subsequently decreased from 20.25 per 100,000 in 2015 to 3.44 per 100,000 in 2019. Most of ZIKV infections clustered in Latin America. The proportion of episodes in Central and Tropical Latin America decreased in 2019 with sporadic episodes elsewhere. High Socio-Demographic Index (SDI) regions had more episodes in 2019 than in 2015. Additionally, 15–49 years group had the largest proportion of episodes, females had a higher number of episodes, and a higher incidence rate of 70 plus group was observed in males than females. Certain cities in Europe, North America and Latin America/Caribbean had a high population mobility in ZIKV outbreak areas considered a high risk of imported cases. ZIKV infection is still a public health threat in Latin America and Caribbean and high SDI regions suffered an increasing trend of ZIKV infection. Interventions such as development of surveillance networks and vector-control should be attached to ZIKV control in these key regions. Reproductive suggestions should be taken to reduce ZIKV-related birth defects for the people of reproductive age who are facing a higher threat of ZIKV infection, especially females. Moreover, surveillance of travellers is needed to reverse the uptrends of travel-related imported ZIKV infection. More studies focusing on ZIKV should be performed to make targeted and effective prevention strategies in the future. Zika virus (ZIKV) infection is a mosquito-borne illness and has potential result in severe birth effects. Currently, ZIKV is still causing an unprecedented ongoing epidemic in Latin America and threatening North America and potentially the rest of the world. This is the first study to assess the global landscape, long-term trends and regional differences in the incidence of ZIKV infection using the data from Global Burden of Disease (GBD) Study 2019, including the description of ZIKV infection episodes by different sex and by different year group, as well as the relationship between international travellers and imported ZIKV cases. Our study can not only serve as complement to previous studies, but also provide a more comprehensive perspective of global ZIKV infection prevention strategies.

Zika virus: The transboundary pathogen from mosquito and updates.

The emergence of Zika virus and its new clinical syndromes

Zika virus tropism and pathogenesis: understanding clinical impacts and transmission dynamics

Hide and Seek: The Interplay Between Zika Virus and the Host Immune Response

Zika Virus—A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and Neuropathogenesis

Prevention and control of Zika fever as a mosquito-borne and sexually transmitted disease

ON STRONG PRODUCT OF GRAPHS

The mechanisms of Zika virus-induced neuropathogenesis

Advances in Zika Virus–Host Cell Interaction: Current Knowledge and Future Perspectives

Mediastinal infection after cardiac operation. A simple closed technique.

From Mosquito Bites to Sexual Transmission: Evaluating Mouse Models of Zika Virus Infection

Zika virus reservoirs: Implications for transmission, future outbreaks, drug and vaccine development

The global trends and regional differences in incidence of Zika virus infection and implications for Zika virus infection prevention

Zika Virus Neuropathogenesis-Research and Understanding

Improvement of Recognition on a Multi-Modal Pattern Discrimination Test

Flow cytometric analysis of decay‐accelerating factor (CD55) on neutrophils from aplastic anaemia patients

Zika vector competence data reveals risks of outbreaks: the contribution of the European ZIKAlliance project

Molecular and cellular insights into Zika virus-related neuropathies

Recent advances in the study of zika virus structure, drug targets, and inhibitors

Research progress of Zika virus and its vaccine

Antiviral Agents in Development for Zika Virus Infections